Processa Pharmaceuticals, Inc. SEC filings PCSA
Processa Pharmaceuticals, Inc. has 705 filings in SEC EDGAR's recent list, going back to Oct 28, 2011. Its latest annual report, Form 10-K, was filed on Mar 18, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Nov 5, 2026 | — |
| DEFA14A | Additional proxy material | Nov 5, 2026 | — |
| 8-K |
Current report
Other events
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Officer or director change, Other events
|
Nov 4, 2026 | Nov 2, 2026 |
| 8-K |
Current report
Other events
|
Oct 29, 2026 | Oct 27, 2026 |
| EFFECT | Filing | Oct 23, 2026 | — |
| DEF 14A | Proxy statement | Oct 22, 2026 | Nov 30, 2026 |
| PRE 14A | Preliminary proxy statement | Oct 9, 2026 | Oct 9, 2026 |
| PRE 14A | Preliminary proxy statement | Oct 9, 2026 | Oct 9, 2026 |
| S-3 | Shelf registration | Oct 9, 2026 | — |
| 8-K/A |
Amended current report
Other events
|
Oct 5, 2026 | Jul 23, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Aug 4, 2026 | Jul 30, 2026 |
| 8-K |
Current report
Material agreement, Agreement ended, Acquisition or sale of assets, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Jul 29, 2026 | Jul 23, 2026 |
| DEF 14A | Proxy statement | Jun 18, 2026 | Jun 18, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 10-K/A | Amended annual report | Apr 30, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 30, 2026 | Apr 30, 2026 |
| 10-K | Annual report | Mar 18, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Agreement ended
|
Feb 19, 2026 | Feb 12, 2026 |
| 8-K |
Current report
Other events
|
Jan 7, 2026 | Jan 6, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Dec 15, 2025 | Dec 12, 2025 |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| S-8 | Employee stock plan registration | Sep 22, 2025 | — |
| 8-K/A |
Amended current report
Bylaw or fiscal year change, Shareholder vote results
|
Sep 16, 2025 | Sep 11, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Sep 12, 2025 | Sep 11, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Sep 10, 2025 | Sep 10, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Sep 2, 2025 | Sep 2, 2025 |
| DEFA14A | Additional proxy material | Aug 25, 2025 | — |
| 8-K |
Current report
Other events
|
Aug 25, 2025 | Aug 25, 2025 |
| 8-K/A |
Amended current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Aug 14, 2025 | Aug 4, 2025 |
| UPLOAD | Letter from the SEC | Aug 13, 2025 | — |
| DEF 14A | Proxy statement | Aug 13, 2025 | Aug 13, 2025 |
| 8-K |
Current report
Listing notice
|
Aug 8, 2025 | Aug 7, 2025 |
| CORRESP | Letter to the SEC | Aug 8, 2025 | — |
| PRER14A | Filing | Aug 8, 2025 | — |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Aug 7, 2025 | Aug 4, 2025 |
| UPLOAD | Letter from the SEC | Aug 6, 2025 | — |
| PRE 14A | Preliminary proxy statement | Jul 31, 2025 | Jul 31, 2025 |
| 8-K |
Current report
Other events
|
Jul 25, 2025 | Jul 25, 2025 |
| 424B5 | Prospectus supplement | Jul 25, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
Jul 18, 2025 | Jul 18, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jul 15, 2025 | Jul 15, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jul 1, 2025 | Jun 27, 2025 |
| 8-K |
Current report
Material agreement, Shareholder vote results
|
Jun 30, 2025 | Jun 24, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 18, 2025 | Jun 17, 2025 |
| 424B4 | Prospectus | Jun 18, 2025 | — |
| EFFECT | Filing | Jun 17, 2025 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 17, 2025 | Jun 17, 2025 |
| CORRESP | Letter to the SEC | Jun 13, 2025 | — |
| CORRESP | Letter to the SEC | Jun 13, 2025 | — |
| S-1 | Registration statement | Jun 13, 2025 | — |
| DEF 14A | Proxy statement | May 12, 2025 | May 12, 2025 |
| DEFA14A | Additional proxy material | May 12, 2025 | — |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| UPLOAD | Letter from the SEC | May 7, 2025 | — |
| PRE 14A | Preliminary proxy statement | May 1, 2025 | May 1, 2025 |
| DRSLTR | Filing | May 1, 2025 | — |
| DRS | Filing | May 1, 2025 | — |
| 10-K | Annual report | Mar 20, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 11, 2025 | Feb 11, 2025 |
| 8-K |
Current report
Listing notice
|
Feb 10, 2025 | Feb 4, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jan 30, 2025 | Jan 27, 2025 |
| 424B4 | Prospectus | Jan 29, 2025 | — |
| EFFECT | Filing | Jan 27, 2025 | — |
| CORRESP | Letter to the SEC | Jan 27, 2025 | — |
| CORRESP | Letter to the SEC | Jan 27, 2025 | — |
| S-1/A | Amended registration statement | Jan 27, 2025 | — |
| CORRESP | Letter to the SEC | Jan 23, 2025 | — |
| CORRESP | Letter to the SEC | Jan 23, 2025 | — |
| CORRESP | Letter to the SEC | Jan 17, 2025 | — |
| CORRESP | Letter to the SEC | Jan 17, 2025 | — |
| S-1/A | Amended registration statement | Jan 16, 2025 | — |
| UPLOAD | Letter from the SEC | Dec 30, 2024 | — |
| S-1 | Registration statement | Dec 20, 2024 | — |
| 8-K |
Current report
Auditor change
|
Nov 6, 2024 | Oct 31, 2024 |
| 10-Q | Quarterly report | Oct 30, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Other events
|
Oct 2, 2024 | Oct 2, 2024 |
| 8-K |
Current report
Other events
|
Aug 28, 2024 | Aug 28, 2024 |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Other events
|
Jul 30, 2024 | Jul 30, 2024 |
| S-8 | Employee stock plan registration | Jul 22, 2024 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 17, 2024 | Jul 16, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jul 2, 2024 | Jun 28, 2024 |
| DEFR14A | Filing | Jun 11, 2024 | — |
| EFFECT | Filing | May 28, 2024 | — |
| 424B5 | Prospectus supplement | May 28, 2024 | — |
| CORRESP | Letter to the SEC | May 24, 2024 | — |
| UPLOAD | Letter from the SEC | May 23, 2024 | — |
| 8-K |
Current report
Material agreement
|
May 21, 2024 | May 21, 2024 |
| S-3 | Shelf registration | May 21, 2024 | — |
| 10-Q | Quarterly report | May 10, 2024 | Mar 31, 2024 |
| DEFA14A | Additional proxy material | Apr 29, 2024 | — |
| DEF 14A | Proxy statement | Apr 29, 2024 | Apr 29, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 11, 2024 | Apr 11, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 4, 2024 | Apr 3, 2024 |
| 10-K | Annual report | Mar 29, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 21, 2024 | Feb 20, 2024 |
| 8-K |
Current report
Other events
|
Feb 6, 2024 | Feb 6, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jan 30, 2024 | Jan 26, 2024 |
| 424B4 | Prospectus | Jan 29, 2024 | — |
| EFFECT | Filing | Jan 26, 2024 | — |
| 8-K |
Current report
Other events
|
Jan 25, 2024 | Jan 25, 2024 |
| CORRESP | Letter to the SEC | Jan 22, 2024 | — |
| CORRESP | Letter to the SEC | Jan 22, 2024 | — |
| S-1/A | Amended registration statement | Jan 22, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 19, 2024 | Jan 19, 2024 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Jan 18, 2024 | Jan 18, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 8, 2024 | Jan 8, 2024 |
| UPLOAD | Letter from the SEC | Jan 5, 2024 | — |
| S-1 | Registration statement | Dec 29, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 19, 2023 | Dec 19, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 5, 2023 | Dec 5, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 16, 2023 | Nov 16, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Nov 15, 2023 | Nov 14, 2023 |
| 10-Q | Quarterly report | Nov 13, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Officer or director change
|
Nov 13, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 16, 2023 | Oct 16, 2023 |
| DEFA14A | Additional proxy material | Oct 5, 2023 | — |
| DEF 14A | Proxy statement | Oct 5, 2023 | Oct 5, 2023 |
| PRE 14A | Preliminary proxy statement | Sep 25, 2023 | Sep 25, 2023 |
| 8-K |
Current report
Listing notice, Bylaw or fiscal year change
|
Sep 21, 2023 | Sep 18, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 17, 2023 | Aug 17, 2023 |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 8, 2023 | Aug 8, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 29, 2023 | Jun 27, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 21, 2023 | Jun 21, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
May 24, 2023 | May 24, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
May 18, 2023 | May 18, 2023 |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
May 8, 2023 | May 6, 2023 |
| ARS | Annual report to shareholders | May 1, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | May 1, 2023 | — |
| DEF 14A | Proxy statement | May 1, 2023 | May 1, 2023 |
| PRE 14A | Preliminary proxy statement | Apr 14, 2023 | Apr 14, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 31, 2023 | Mar 30, 2023 |
| 10-K | Annual report | Mar 30, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Listing notice
|
Mar 22, 2023 | Mar 22, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 14, 2023 | Mar 14, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Feb 13, 2023 | Feb 9, 2023 |
| 424B5 | Prospectus supplement | Feb 13, 2023 | — |
| 8-K |
Current report
Other events
|
Feb 6, 2023 | Feb 6, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 22, 2022 | Dec 22, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 14, 2022 | Dec 14, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 8, 2022 | Nov 8, 2022 |
| 10-Q | Quarterly report | Nov 8, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Other events
|
Nov 4, 2022 | Nov 2, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 7, 2022 | Sep 7, 2022 |
| S-8 | Employee stock plan registration | Aug 16, 2022 | — |
| 8-K |
Current report
Results of operations
|
Aug 12, 2022 | Aug 12, 2022 |
| 10-Q | Quarterly report | Aug 11, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 4, 2022 | Aug 4, 2022 |
| 8-K |
Current report
Officer or director change
|
Jul 25, 2022 | Jul 19, 2022 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jul 14, 2022 | Jul 11, 2022 |
| DEFA14A | Additional proxy material | May 31, 2022 | — |
| DEF 14A | Proxy statement | May 31, 2022 | May 31, 2022 |
| 8-K |
Current report
Other events
|
May 16, 2022 | May 16, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
May 12, 2022 | May 12, 2022 |
| 10-Q | Quarterly report | May 12, 2022 | Mar 31, 2022 |
| 10-K/A | Amended annual report | May 2, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Mar 30, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Material agreement
|
Mar 24, 2022 | Mar 23, 2022 |
| 424B5 | Prospectus supplement | Mar 24, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 17, 2022 | Mar 17, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 26, 2022 | Jan 26, 2022 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Jan 6, 2022 | Jan 1, 2022 |
| 10-Q | Quarterly report | Nov 12, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Nov 5, 2021 | Nov 3, 2021 |
| DEFA14A | Additional proxy material | Sep 20, 2021 | — |
| DEF 14A | Proxy statement | Sep 20, 2021 | Sep 20, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 20, 2021 | Sep 20, 2021 |
| PRE 14A | Preliminary proxy statement | Sep 1, 2021 | Sep 1, 2021 |
| 424B5 | Prospectus supplement | Aug 20, 2021 | — |
| 8-K |
Current report
Material agreement
|
Aug 20, 2021 | Aug 20, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2021 | Aug 12, 2021 |
| 10-Q | Quarterly report | Aug 12, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 30, 2021 | Jul 29, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 15, 2021 | Jul 15, 2021 |
| EFFECT | Filing | Jul 9, 2021 | — |
| CORRESP | Letter to the SEC | Jul 6, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 6, 2021 | — |
| S-3 | Shelf registration | Jun 30, 2021 | — |
| S-8 | Employee stock plan registration | Jun 30, 2021 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 17, 2021 | Jun 16, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2021 | Jun 10, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 9, 2021 | Jun 9, 2021 |
| 8-K |
Current report
Agreement ended
|
May 26, 2021 | May 25, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
May 20, 2021 | May 20, 2021 |
| 8-K |
Current report
Results of operations
|
May 13, 2021 | May 13, 2021 |
| 10-Q | Quarterly report | May 13, 2021 | Mar 31, 2021 |
| DEFA14A | Additional proxy material | Apr 26, 2021 | — |
| DEF 14A | Proxy statement | Apr 22, 2021 | Apr 22, 2021 |
| EFFECT | Filing | Apr 12, 2021 | — |
| 424B3 | Prospectus | Apr 12, 2021 | — |
| CORRESP | Letter to the SEC | Apr 7, 2021 | — |
| 10-K/A | Amended annual report | Apr 7, 2021 | Dec 31, 2020 |
| UPLOAD | Letter from the SEC | Apr 5, 2021 | — |
| S-3 | Shelf registration | Apr 2, 2021 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PCSA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Vero Beach, FL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1533743
- Former names
- Heatwurx, Inc. (until Oct 20, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.